PPD Clinical Research Associates Recognized for Excellence


WILMINGTON, N.C.--(BUSINESS WIRE)--Pharmaceutical Product Development, LLC (PPD) today announced industry accolades earned by PPD clinical research associates (CRAs), recognizing their expertise in the endeavor of developing life-changing medicines.

A four-person team of PPD CRAs won the gold award for Clinical Research Team of the Year at the PharmaTimes International Clinical Researcher of the Year in London. And at the PharmaTimes Clinical Researcher of the Year—The Americas competition, two PPD CRAs were honored in Seattle, Washington. Both competitions were a culmination of a demanding year long, three-part series of tests, including real-life challenges judged by industry leaders.

The industry recognition demonstrates the high caliber of PPD’s clinical research associates and PPD’s award-winning training and development programs, such as the Virtual Clinical Foundations Program 2.0, which help to prepare research professionals for successful clinical trial monitoring, and to deliver performance, quality and value to clients and their studies.

“PPD’s clinical researchers are focused on and dedicated to providing the best for their clinical trials and our clients,” said Roger Newbery, senior vice president of clinical management for PPD. “I am proud that their talent and hard work has been recognized in this way.”

In London, the PPD team was awarded gold at the event finale on May 18. At the celebration in Seattle, the PPD CRAs received the gold award in the Experienced CRA category and the bronze award in the New CRA category. The event was created in 1999 to provide clinical research professionals an opportunity to benchmark their professional skills against their peers in a program of competency-based exercises developed through cross-industry collaboration.

About PPD

PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 47 countries and more than 19,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a firm commitment to quality to help clients and partners bend the cost and time curve of drug development to deliver life-changing therapies that improve health. For more information, visit www.ppdi.com.

It's on us. Share your news here.

Submit your stories and articles to citybizlist today.